Revisiting the term neuroprotection in chronic and degenerative diseases
Nascimento, Osvaldo J. M.
Matta, Andre P. C.
Melo Reis, Carlos Henrique
de Souza, Olivia Gameiro
Bastos, Victor Hugo
Morales, Pedro S.
Moreira Filho, Pedro F.
Trajano, Eduardo Lima
Oliveira, Acary Bulle [UNIFESP]
Is part ofNeurology International
MetadataShow full item record
Thanks to the development of several new researches, the lifetime presented a significant increase, even so, we still have many obstacles to overcome - among them, manage and get responses regarding neurodegenerative diseases. Where we are in the understanding of neuroprotection? Do we really have protective therapies for diseases considered degeneratives such as amyotrophic lateral sclerosis and its variants, Parkinson's disease, Alzheimer's disease and many others? Neuroprotection is defined by many researches as interactions and interventions that can slow down or even inhibit the progression of neuronal degeneration process. We make some considerations on this neuroprotective effect.
CitationNeurology International. Pavia, v. 8, n. 1, p. UNSP 6311, 2016.
- EPM - Artigos